<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35433731</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2296-858X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>9</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in medicine</Title>
          <ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of Hydrogen Inhalation Therapy on Hearing Loss of Patients With Nasopharyngeal Carcinoma After Radiotherapy.</ArticleTitle>
        <Pagination>
          <StartPage>828370</StartPage>
          <MedlinePgn>828370</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">828370</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.828370</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To evaluate the clinical efficacy and safety of hydrogen inhalation in improving hearing loss in patients with long-term survival of nasopharyngeal carcinoma after radiotherapy.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The eustachian tube dysfunction score, pure tone air conduction threshold, bone conduction threshold, the score of tympanogram and otoscope were prospectively observed in patients with deafness after radiotherapy only or combined radiotherapy and chemotherapy for nasopharyngeal carcinoma. Paired t test and one-way analysis of variance were used to analyze the data before and after treatment.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 17 patients were observed. The median time from radiotherapy to now was 228 months, and the median time from the diagnose of deafness to now was 92 months. After 4 weeks of hydrogen inhalation, the score of eustachian tube dysfunction, air conduction and bone conduction hearing thresholds were significantly reduced, <i>P</i> values were 0.0293, 0.0027, 0.0404, respectively. The mean air-bone gap, the score of otoendoscopy and tympanogram were also decreased, but the differences were not significant (<i>P</i> = 0.2079, <i>P</i> = 0.0536, <i>P</i> = 0.1056). Patients with radiotherapy alone and concurrent chemo-radiotherapy had significantly lower air conduction hearing threshold after hydrogen absorption (<i>P</i> = 0.0142, <i>P</i> = 0.0495). The results of air and bone hearing thresholds before, 4 and 12 weeks after hydrogen inhalation showed a descending trend. The air and bone hearing thresholds before hydrogen inhalation were 74.69 ± 27.03 dB and 45.70 ± 21.58 dB, respectively. At the 12th week, the mean values of air and bone hearing thresholds were the lowest, which were 66.88 ± 20.88 dB and 40.94 ± 18.93 dB, respectively, but there was no significant difference in air and bone hearing thresholds among all groups (<i>P</i> = 0.6755, <i>P</i> = 0.7712). After hydrogen inhalation treatment, no adverse reactions such as nosebleed, chest pain, dyspnea, nausea, vomiting, dizziness, earache and allergic reaction were observed.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This is the first prospective study on the effect of hydrogen inhalation on hearing improvement in patients with deafness after radiotherapy/chemotherapy for nasopharyngeal carcinoma, suggesting that continuous hydrogen inhalation may be an alternative rehabilitation therapy for these patients.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Kong, Lu, Lu, Yin and Xu.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kong</LastName>
            <ForeName>Xiaofeng</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Hydrogen Medicine Institute, The Biomedical Translational Research Institute, Jinan University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Tianyu</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Fuda Cancer Hospital, Jinan University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>You-Yong</ForeName>
            <Initials>YY</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Laboratory of Molecular Oncology, Peking University Cancer Hospital &amp; Institute, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yin</LastName>
            <ForeName>Zhinan</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medical Science, The Biomedical Translational Research Institute, Jinan University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Kecheng</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Fuda Cancer Hospital, Jinan University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Med (Lausanne)</MedlineTA>
        <NlmUniqueID>101648047</NlmUniqueID>
        <ISSNLinking>2296-858X</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">chemotherapy</Keyword>
        <Keyword MajorTopicYN="N">hearing impairment</Keyword>
        <Keyword MajorTopicYN="N">hearing loss</Keyword>
        <Keyword MajorTopicYN="N">hydrogen inhalation</Keyword>
        <Keyword MajorTopicYN="N">hydrogen oxygen inhalation</Keyword>
        <Keyword MajorTopicYN="N">nasopharyngeal carcinoma</Keyword>
        <Keyword MajorTopicYN="N">radiotherapy</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>39</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35433731</ArticleId>
        <ArticleId IdType="pmc">PMC9008775</ArticleId>
        <ArticleId IdType="doi">10.3389/fmed.2022.828370</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lin C, Lin SW, Weng SF, Lin YS. Risk of developing sudden sensorineural hearing loss in patients with nasopharyngeal carcinoma: a population-based cohort study. Head Neck. (2014) 36:203–8. 10.1002/hed.23278</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hed.23278</ArticleId>
            <ArticleId IdType="pubmed">23780872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, et al. . Treatment results for nasopharyngeal carcinoma in the modern era:the Hong Kong experience. Int J Radiat Oncol Biol Phys. (2005) 61:1107–16. 10.1016/j.ijrobp.2004.07.702</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijrobp.2004.07.702</ArticleId>
            <ArticleId IdType="pubmed">15752890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol. (2004) 22:4604–12. 10.1200/JCO.2004.10.074</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/JCO.2004.10.074</ArticleId>
            <ArticleId IdType="pubmed">15542811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang MX Li J, Shen GP, Zou X, Xu JJ, Jiang R, et al. . Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up. Eur J Cancer. (2015) 51:2587–95. 10.1016/j.ejca.2015.08.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejca.2015.08.006</ArticleId>
            <ArticleId IdType="pubmed">26318726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Chen YY, Tai A, Chen XL, Huang SM, Yang C, et al. . Sensorineural hearing loss after combined intensity modulated radiation therapy and cisplatin-based chemotherapy for nasopharyngeai carcinoma. TransIational oncology. (2015) 8:456–62. 10.1016/j.tranon.2015.10.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tranon.2015.10.003</ArticleId>
            <ArticleId IdType="pmc">PMC4700287</ArticleId>
            <ArticleId IdType="pubmed">26692526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei Y, Zhou T, Zhu J, Zhang Y, Sun M, Ding X, et al. . Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy. Cell Biochem Biophys. (2014) 69:433–7. 10.1007/s12013-014-9814-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12013-014-9814-x</ArticleId>
            <ArticleId IdType="pubmed">24510513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu W, Chen F, Li J, Wang W, Zhang H, Yang G, et al. . Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma. Acta Otolaryngol. (2019) 139:263–8. 10.1080/00016489.2019.1566778</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00016489.2019.1566778</ArticleId>
            <ArticleId IdType="pubmed">30870056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee A W, Lin J C, Ng W T. Current management of nasopharyngeal cancer. Semin Radiat Oncol. (2012) 22:233–44. 10.1016/j.semradonc.2012.03.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semradonc.2012.03.008</ArticleId>
            <ArticleId IdType="pubmed">22687948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dole M, Wilson FR, Fife WP. Hyperbaric hydrogen therapy: a possible treatment for cancer. Science. (1975) 190:152–4. 10.1126/science.1166304</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1166304</ArticleId>
            <ArticleId IdType="pubmed">1166304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gharib B, Hanna S, Abdallahi OM, Lepidi H, Gardette B, De Reggi M. Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver inflammation. C R Acad Sci III. (2001) 324:719–24. 10.1016/S0764-4469(01)01350-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0764-4469(01)01350-6</ArticleId>
            <ArticleId IdType="pubmed">11510417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, et al. . Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. (2007). 13(6):688-694. 10.1038/nm1577</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1577</ArticleId>
            <ArticleId IdType="pubmed">17486089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ge L, Yang M, Yang NN, Yin XX, Song WG. Molecular hydrogen: a preventive and therapeutic medical gas for various diseases. Oncotarget. (2017) 8:102653–73. 10.18632/oncotarget.21130</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.21130</ArticleId>
            <ArticleId IdType="pmc">PMC5731988</ArticleId>
            <ArticleId IdType="pubmed">29254278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang D, Wang L, Zhang Y, Zhao Y, Chen G. Hydrogen gas inhibits lung cancer progression through targeting SMC3. Biomed Pharmacother. (2018) 104:788–97. 10.1016/j.biopha.2018.05.055</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2018.05.055</ArticleId>
            <ArticleId IdType="pubmed">29852353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y, Liu PY, Bao W, Chen SJ, Wu FS, Zhu PY. Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway. BMC Cancer. (2020) 20:28. 10.1186/s12885-019-6491-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12885-019-6491-6</ArticleId>
            <ArticleId IdType="pmc">PMC6954594</ArticleId>
            <ArticleId IdType="pubmed">31924176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li S, Liao R, Sheng X, Luo X, Zhang X, Wen X, et al. . Hydrogen gas in cancer treatment. Front Oncol. (2019) 9:696. 10.3389/fonc.2019.00696</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2019.00696</ArticleId>
            <ArticleId IdType="pmc">PMC6691140</ArticleId>
            <ArticleId IdType="pubmed">31448225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kikkawa YS, Nakagawa T, Horie RT, Ito J. Hydrogen protects auditory hair cells from free radicals. Neuroreport. (2009) 20:689–94. 10.1097/WNR.0b013e32832a5c68</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/WNR.0b013e32832a5c68</ArticleId>
            <ArticleId IdType="pubmed">19339905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin Y, Kashio A, Sakamoto T, Suzukawa K, Kakigi A, Yamasoba T. Hydrogen in drinking water attenuates noise-induced hearing loss in guinea pigs. Neurosci Lett. (2011) 487:12–6. 10.1016/j.neulet.2010.09.064</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neulet.2010.09.064</ArticleId>
            <ArticleId IdType="pubmed">20888392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y, Zheng H, Ruan F, Chen X, Zheng G, Kang M, et al. . Hydrogen-rich saline alleviates experimental noise-induced hearing loss in guinea pigs. Neuroscience. (2012) 209:47–53. 10.1016/j.neuroscience.2012.02.028</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2012.02.028</ArticleId>
            <ArticleId IdType="pubmed">22387110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L, Yu N, Lu Y, Wu L, Chen D, Guo W, et al. . Hydrogen-saturated saline protects intensive narrow band noise-induced hearing loss in guinea pigs through an antioxidant effect. PLoS ONE. (2014) 9:e100774. 10.1371/journal.pone.0100774</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0100774</ArticleId>
            <ArticleId IdType="pmc">PMC4063935</ArticleId>
            <ArticleId IdType="pubmed">24945316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCoul ED, Anand VK. Christos PJ. Validating the clinical assessment of eustachian tube dysfunction: the Eustachian tube dysfunction questionnaire (ETDQ-7). Laryngoscope. (2012) 122:1137–41. 10.1002/lary.23223</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/lary.23223</ArticleId>
            <ArticleId IdType="pmc">PMC3612400</ArticleId>
            <ArticleId IdType="pubmed">22374681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tarabichi M, Poe DS, Nogueira JF, Alicandri-Ciufelli M, Badr-El-Dine M, Cohen MS, et al. . The eustachian tube redefined. Otolaryngol Clin North Am. (2016) 49:XVII–XX. 10.1016/j.otc.2016.07.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.otc.2016.07.013</ArticleId>
            <ArticleId IdType="pubmed">27565395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>US US Department of Health and Human Services National National Institutes of Health(NIH) and National Cancer Institute (NCI) . Common terminology criteria for adverse events (CTCAE) version 4.0 [EB/OL].
Bethesda, NIH Publication.</Citation>
        </Reference>
        <Reference>
          <Citation>Au KH, Ngan RKC, Ng AWY, Poon DMC, Ng WT, Yuen KT, et al. . Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study). Oral Oncol. (2018) 77:16–21. 10.1016/j.oraloncology.2017.12.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.oraloncology.2017.12.004</ArticleId>
            <ArticleId IdType="pubmed">29362121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Low WK, Toh ST, Wee J, Fook-Chong SM, Wang DY. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study. J Clin Oncol. (2006) 24:1904–9. 10.1200/JCO.2005.05.0096</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/JCO.2005.05.0096</ArticleId>
            <ArticleId IdType="pubmed">16622266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young YH, Lou PJ. Post-irradiation sudden deafness. J Laryngol Otol. (1999) 113:815–7. 10.1017/S0022215100145281</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0022215100145281</ArticleId>
            <ArticleId IdType="pubmed">10664683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yilmaz YF, Aytas FI, Akdogan O, Sari K, Savas ZG, Titiz A, et al. . Sensorineural hearing loss after radiotherapy for head and neck tumors: a prospective study of the effect of radiation. Otol Neurotol. (2008) 29:461–3. 10.1097/MAO.0b013e31816c7c9e</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MAO.0b013e31816c7c9e</ArticleId>
            <ArticleId IdType="pubmed">18520582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng Y, Han F, Xiao W, Xiang Y, Lu L, Deng X, et al. . Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy. Radiat Oncol. (2015) 10:17. 10.1186/s13014-014-0326-z</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13014-014-0326-z</ArticleId>
            <ArticleId IdType="pmc">PMC4302701</ArticleId>
            <ArticleId IdType="pubmed">25582731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDowell LJ, Rock K, Xu W, Chan B, Waldron J, Lu L, et al. . Long-term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. (2018) 102:340–52. 10.1016/j.ijrobp.2018.05.060</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijrobp.2018.05.060</ArticleId>
            <ArticleId IdType="pubmed">30191868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang TL, Chien CY, Tsai WL, Liao KC, Chou SY, Lin HC, et al. . Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy. Head Neck. (2016) 38:E1026–32. 10.1002/hed.24150</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hed.24150</ArticleId>
            <ArticleId IdType="pubmed">26041548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lan XH, Tang AZ, Zhou Y. The audiologic study of the long-term survivors with Nasopharyngeal carcinoma after radiotherapy. Can J Speech-Lang Pathol Audiol. (2012) 20:336–8. 10.3969/j.issn.1006-7299.2012.4.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3969/j.issn.1006-7299.2012.4.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michels TC, Duffy MT, Rogers DJ. Hearing Loss in Adults: Differential Diagnosis and Treatment. Am Fam Physician. (2019) 100:98–108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31305044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng Y, Xiong S, Cheng Y, Qi YF, Yang Y. Clinical investigation of different routes of administration of dexamethasone on sudden deafness. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. (2008) 22:442–5. 10.3969/j.issn.1001-1781.2008.10.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3969/j.issn.1001-1781.2008.10.004</ArticleId>
            <ArticleId IdType="pubmed">18720882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J, Kong X, Mu F, Lu T, Du D, Xu K. Hydrogen-oxygen therapy can alleviate radiotherapy-induced hearing loss in patients with nasopharyngeal cancer. Ann Palliat Med. (2019) 8:746–51. 10.21037/apm.2019.11.18</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21037/apm.2019.11.18</ArticleId>
            <ArticleId IdType="pubmed">31865734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kam WW, Banati RB. Effects of ionizing radiation on mitochondria. Free Radic Biol Med. (2013) 65:607–19. 10.1016/j.freeradbiomed.2013.07.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.07.024</ArticleId>
            <ArticleId IdType="pubmed">23892359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faraonio R, Vergara P, Di Marzo D, Pierantoni MG, Napolitano M, Russo T, et al. . p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem. (2006) 281:39776–84. 10.1074/jbc.M605707200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M605707200</ArticleId>
            <ArticleId IdType="pubmed">17077087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hus MM, Young YH. Lin KL. Eustachian tube function of patients with nasopharyngeal carcinoma. Ann Oto Rhinol Laryngol. (1995) 104:453–5. 10.1177/000348949510400607</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/000348949510400607</ArticleId>
            <ArticleId IdType="pubmed">7771718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Low WK, Burgess R, Fong KW. Wang DY. Effect of Radiotherapy on Retro-Cochlear Auditory Pathways. The Laryngoscope. (2005) 115:1823–6. 10.1097/01.mlg.0000175061.59315.58</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.mlg.0000175061.59315.58</ArticleId>
            <ArticleId IdType="pubmed">16222203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang SZ, Chen ZC, McNamar JP, Wang SY. Cheng QF. The relationship between the protective effect of amifostine and decreased intercellular adhesion molecule expression. Am J Otolaryngol Head Neck Med Surg. (2005) 26:118–22. 10.1016/j.amjoto.2004.11.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjoto.2004.11.002</ArticleId>
            <ArticleId IdType="pubmed">15742265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao J, Luo ZQ, Shi DZ, Huang YJ, Tan YF. Short-term results of audiological change of nasopharyngeal carcinoma patient after radiotherapy and chemotherapy. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. (2008) 43:906–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19141241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, et al. . Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. (2002) 53:12–22. 10.1016/S0360-3016(02)02724-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0360-3016(02)02724-4</ArticleId>
            <ArticleId IdType="pubmed">12007936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsin CH, Chen TH, Young YH, Liu WS. Comparison of otologic complications between intensity-modulated and two-dimensional radiotherapies in nasopharyngeal carcinoma patients. Otolaryngol Head Neck Surg. (2010) 143:662–8. 10.1016/j.otohns.2010.07.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.otohns.2010.07.012</ArticleId>
            <ArticleId IdType="pubmed">20974336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young YH, Ko JY, Sheen TS. Post-irradiation dizziness in nasopharyngeal carcinoma survivors. Otol Neurotol. (2004). 25:366–70. 10.1097/00129492-200405000-00027</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00129492-200405000-00027</ArticleId>
            <ArticleId IdType="pubmed">15129119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chi FH. Young YH Inner ear deficits in irradiated nasopharyngeal carcinoma survivors. Laryngoscope. (2015) 125:2565–71. 10.1002/lary.25329</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/lary.25329</ArticleId>
            <ArticleId IdType="pubmed">25945470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsin CH, Chen TH, Liang KL, Tseng HC, Liu WS. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy. Laryngoscope. (2013) 123:2148–53. 10.1002/lary.23215</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/lary.23215</ArticleId>
            <ArticleId IdType="pubmed">23835775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LeBaron TW, Kura B, Kalocayova B, Tribulova N, Slezak J. A new approach for the prevention and treatment of cardiovascular disorders: molecular hydrogen significantly reduces the effects of oxidative stress. Molecules. (2019) 24:2076. 10.3390/molecules24112076</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules24112076</ArticleId>
            <ArticleId IdType="pmc">PMC6600250</ArticleId>
            <ArticleId IdType="pubmed">31159153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nogueira JE, de Deus JL, Amorim MR, Batalhão ME, Leão RM, Carnio EC, et al. . Inhaled molecular hydrogen attenuates intense acute exercise-induced hippocampal inflammation in sedentary rats. Neurosci Lett. (2020) 715:134577. 10.1016/j.neulet.2019.134577</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neulet.2019.134577</ArticleId>
            <ArticleId IdType="pubmed">31715290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nogueira JE, Passaglia P, Mota CMD, Santos BM, Batalhão ME, Carnio EC, et al. . Molecular hydrogen reduces acute exercise-induced inflammatory and oxidative stress status. Free Radic Biol Med. (2018) 129:186–93. 10.1016/j.freeradbiomed.2018.09.028</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.09.028</ArticleId>
            <ArticleId IdType="pubmed">30243702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qu J, Li X, Wang J, Mi W, Xie K, Qiu J. Inhalation of hydrogen gas attenuates cisplatin-induced ototoxicity via reducing oxidative stress. Int J Pediatr Otorhinolaryngol. (2012) 76:111–5. 10.1016/j.ijporl.2011.10.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijporl.2011.10.014</ArticleId>
            <ArticleId IdType="pubmed">22055279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kikkawa YS, Nakagawa T, Taniguchi M, Ito J. Hydrogen protects auditory hair cells from cisplatin-induced free radicals. Neurosci Lett. (2014) 579:125–9. 10.1016/j.neulet.2014.07.025</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neulet.2014.07.025</ArticleId>
            <ArticleId IdType="pubmed">25064701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao YS, An JR, Yang S, Guan P, Yu FY Li W, et al. . Hydrogen and oxygen mixture to improve cardiac dysfunction and myocardial pathological changes induced by intermittent hypoxia in rats. Oxid Med Cell Longev. (2019) 2019:7415212. 10.1155/2019/7415212</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2019/7415212</ArticleId>
            <ArticleId IdType="pmc">PMC6431505</ArticleId>
            <ArticleId IdType="pubmed">30984338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo XY Li XM, She CS, Lu XQ, Xiao CG, Wang SH, et al. . Hydrogen-rich saline protects rat from oxygen glucose deprivation and reperusion-induced apoptosis through VDAC1 via Bcl-2. Brain Res. (2019) 1706:110–5. 10.1016/j.brainres.2018.09.037</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2018.09.037</ArticleId>
            <ArticleId IdType="pubmed">30287344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang B, Wang H, Zhang M, Ji R, Wei J, Xin Y, et al. . Radiation-induced myocardial fibrosis: mechanisms underlying its pathogenesis and therapeutic strategies. J Cell Mol Med. (2020) 24:7717–29. 10.1111/jcmm.15479</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jcmm.15479</ArticleId>
            <ArticleId IdType="pmc">PMC7348163</ArticleId>
            <ArticleId IdType="pubmed">32536032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venkatesulu BP, Mahadevan LS, Aliru ML, Yang X, Bodd MH, Singh PK, et al. . Radiation-induced endothelial vascular injury: a review of possible mechanisms. JACC Basic Transl Sci. (2018) 3:563–72. 10.1016/j.jacbts.2018.01.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacbts.2018.01.014</ArticleId>
            <ArticleId IdType="pmc">PMC6115704</ArticleId>
            <ArticleId IdType="pubmed">30175280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Yang B, Chen X, Zhou Q, Li H, Chen S, et al. . Nobiletin regulates ROS/ADMA/DDAHII/ eNOS/NO pathway and alleviates vascular endothelium injury by iron overload. Biol Trace Elem Res. (2020) 198:87–97. 10.1007/s12011-020-02038-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12011-020-02038-6</ArticleId>
            <ArticleId IdType="pubmed">32002792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Murugesan P, Huang K, Cai H. NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets. Nat Rev Cardiol. (2020) 17:170–94. 10.1038/s41569-019-0260-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41569-019-0260-8</ArticleId>
            <ArticleId IdType="pmc">PMC7880919</ArticleId>
            <ArticleId IdType="pubmed">31591535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ping Z, Peng Y, Lang H, Xinyong C, Zhiyi Z, Xiaocheng W, et al. . Oxidative stress in radiation-induced cardiotoxicity. Oxid Med Cell Longev. (2020) 2020:1–15. 10.1155/2020/3579143</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2020/3579143</ArticleId>
            <ArticleId IdType="pmc">PMC7071808</ArticleId>
            <ArticleId IdType="pubmed">32190171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farhood B, Goradel NH, Mortezaee K, Khanlarkhani N, Salehi E, Nashtaei MS, et al. . Intercellular communications-redox interactions in radiation toxicity; potential targets for radiation mitigation. J Cell Commun Signal. (2019) 13:3–16. 10.1007/s12079-018-0473-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12079-018-0473-3</ArticleId>
            <ArticleId IdType="pmc">PMC6381372</ArticleId>
            <ArticleId IdType="pubmed">29911259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stewart FA, Hoving S, Russell NS. Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat Res. (2010) 174:865–9. 10.1667/RR1862.1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1667/RR1862.1</ArticleId>
            <ArticleId IdType="pubmed">21128810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li CS, Schminke U, Tan TY. Extracranial carotid artery disease in nasopharyngeal carcinoma patients with post-irradiation ischemic stroke. Clin Neurol Neurosurg. (2010) 112:682–6. 10.1016/j.clineuro.2010.05.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clineuro.2010.05.007</ArticleId>
            <ArticleId IdType="pubmed">20579803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young YH, Sheen TS. Preservation of tubal function in patients with nasopharyngeal carcinoma, post-irradiation. Acta Otolaryngol. (1998) 118:280–3. 10.1080/00016489850155026</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00016489850155026</ArticleId>
            <ArticleId IdType="pubmed">9583799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>KC Xu. Hydrogen-Oxygen Inhalation for Treatment of COVID-19.
Singapore: World Sci. (2020) p. 23–25</Citation>
        </Reference>
        <Reference>
          <Citation>Qin ZX Yu P, Qian DH, Song MB, Tan H, Yu Y, et al. . Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-alpha/NF-kappaB pathway. Atherosclerosis. (2012) 220:343–50. 10.1016/j.atherosclerosis.2011.11.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.atherosclerosis.2011.11.002</ArticleId>
            <ArticleId IdType="pubmed">22153150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohsawa I, Nishimaki K, Yamagata K, Ishikawa M, Ohta S. Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice. Biochem Biophys Res Commun. (2008) 377:1195–8. 10.1016/j.bbrc.2008.10.156</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2008.10.156</ArticleId>
            <ArticleId IdType="pubmed">18996093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song G, Zong C, Zhang Z, Yu Y, Yao S, Jiao P, et al. . Molecular hydrogen stabilizes atherosclerotic plaque in low-density lipoprotein receptor-knockout mice. Free Radic Biol Med. (2015) 87:58–68. 10.1016/j.freeradbiomed.2015.06.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.06.018</ArticleId>
            <ArticleId IdType="pubmed">26117323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fransson AE, Videhult Pierre P, Risling M, Laurell GFE. Inhalation of molecular hydrogen, a rescue treatment for noise-induced hearing loss. Front Cell Neurosci. (2021) 15:658662. 10.3389/fncel.2021.658662</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2021.658662</ArticleId>
            <ArticleId IdType="pmc">PMC8205059</ArticleId>
            <ArticleId IdType="pubmed">34140880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou ZQ, Zhong CH, Su ZQ Li XY, Chen Y, Chen XB, et al. . Breathing hydrogen-oxygen mixture decreases inspiratory effort in patients with tracheal stenosis. Respiration. (2019) 97:42–51. 10.1159/000492031
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000492031</ArticleId>
            <ArticleId IdType="pubmed">30227423</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
